1. Home
  2. DNLI vs EVTC Comparison

DNLI vs EVTC Comparison

Compare DNLI & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • EVTC
  • Stock Information
  • Founded
  • DNLI 2013
  • EVTC 1988
  • Country
  • DNLI United States
  • EVTC United States
  • Employees
  • DNLI N/A
  • EVTC N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • EVTC EDP Services
  • Sector
  • DNLI Health Care
  • EVTC Technology
  • Exchange
  • DNLI Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • DNLI 2.3B
  • EVTC 2.2B
  • IPO Year
  • DNLI 2017
  • EVTC 2013
  • Fundamental
  • Price
  • DNLI $15.21
  • EVTC $31.10
  • Analyst Decision
  • DNLI Strong Buy
  • EVTC Hold
  • Analyst Count
  • DNLI 15
  • EVTC 5
  • Target Price
  • DNLI $33.50
  • EVTC $39.00
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • EVTC 347.2K
  • Earning Date
  • DNLI 11-05-2025
  • EVTC 11-05-2025
  • Dividend Yield
  • DNLI N/A
  • EVTC 0.64%
  • EPS Growth
  • DNLI N/A
  • EVTC 102.95
  • EPS
  • DNLI N/A
  • EVTC 2.13
  • Revenue
  • DNLI N/A
  • EVTC $886,589,000.00
  • Revenue This Year
  • DNLI N/A
  • EVTC $9.23
  • Revenue Next Year
  • DNLI $95,463.19
  • EVTC $4.84
  • P/E Ratio
  • DNLI N/A
  • EVTC $14.58
  • Revenue Growth
  • DNLI N/A
  • EVTC 12.93
  • 52 Week Low
  • DNLI $10.57
  • EVTC $30.00
  • 52 Week High
  • DNLI $33.33
  • EVTC $38.56
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 54.76
  • EVTC 32.28
  • Support Level
  • DNLI $15.03
  • EVTC $31.95
  • Resistance Level
  • DNLI $16.51
  • EVTC $32.36
  • Average True Range (ATR)
  • DNLI 0.80
  • EVTC 0.75
  • MACD
  • DNLI 0.11
  • EVTC -0.21
  • Stochastic Oscillator
  • DNLI 61.42
  • EVTC 23.09

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

Share on Social Networks: